Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives

BACKGROUND: Real-world evidence (RWE) can provide postmarket data to inform whether funded cancer drugs yield expected outcomes and value for money, but it is unclear how to incorporate RWE into Canadian cancer drug funding decisions. As part of the Canadian Real-World Evidence Value for Cancer Drug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:CMAJ Open
Autores principales: Clausen, Marc, Mighton, Chloe, Kiflen, Ruhi, Sebastian, Agnes, Dai, Wei Fang, Mercer, Rebecca E., Beca, Jaclyn M., Isaranuwatchai, Wanrudee, Chan, Kelvin K.W., Bombard, Yvonne
Formato: Artigo
Lenguaje:Inglês
Publicado: Joule Inc. or its licensors 2020
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7721249/
https://ncbi.nlm.nih.gov/pubmed/33234584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20200118
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares